Archived Insight | March 30, 2020

New York Times Article on Coronavirus and Health Insurance

Segal's Ed Kaplan was included in an in-depth article in The New York Times examining the predicted effect of the coronavirus on health insurance premiums.

Read the article.

Questions about the subject of this article?

Talk to one of our consultants to get the answers you need.

What you'll find in this article

The article discusses how the pandemic has caught insurers and health plans unawares, which could lead to a huge increase in premiums next year. Some of the factors that will determine the fate of premiums include the scope of the pandemic in America, how much it costs to treat COVID-19 patients, and how much financial relief the government will provide.

Learn more from Segal

Female Nutritionist Holding Image Of Healthy Eating Plate

Health Coaching Enhances Well-Being and Productivity

Your organization can derive significant value from integrating health coaching into its existing health-management programs.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Pharmacist Taking Inventory With Digital Tablet

Executive Order Seeks to Lower Prescription Drug Prices

The order instructs federal departments to issue regulations or work with Congress to identify statutory changes necessary to address drug prices.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Asian Senior Woman Reading The Information Sheet Of Her Prescribed Medicine

Implications of Medicare Changes for Group Health Plans

Our insight discusses guidance for sponsors of group health plans as well as a chart showing the impact on Medicare Part D cost sharing in 2026.

Compliance, Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Explore all COVID-19 information

We're regularly publishing information on the coronavirus as the situation changes.

Learn More

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.